news & events

Now through January 21, 2009. NCBC 2009-2008 Mini-Grant Applications Accepted
November 17, 2008. Biotech Forum: Strategic Financing in Biotechnology
November 20, 2008. BIO Regional Briefing
December 4, 2008. Medical Device Seminar
December 4-5, 2008. Southeast BIO's 10th Anniversary Investor Forum
January 14, 2009. CED's Medtech Forum: Orthopedics-Product to Market
February 16-17, 2009. Biotech Conference
March 4, 2009. CED's Medtech Forum
March 16, 2009. CED's Biotech Forum: Emerging Opportunities
May 4, 2009 CED's Biotech Forum: Partnering
May 14, 2009. CED's Medtech 2009 Conference
May 18-21, 2009. BIO 2009 Atlanta, GA

More information on News and Events Page

mission

NCBIO is North Carolina's state-level affiliate of the national Biotechnology Industry Organization. Together, the two groups advocate federal, state and local public policies designed to help the bioscience industry fulfill its extraordinary promise as a source of economic opportunity and improved life quality.

advocacy highlights

Capital Access. Capital is a critical need of all bioscience companies. NCBIO works constantly to expand public investments in bioscience companies and life-science venture funds, loans for bioscience businesses, and tax incentives for investments and research.
Workforce Training and Education. Bioscience companies require highly educated scientists, laboratory technicians, manufacturing workers and other trained employees. North Carolina is spending more than $60 million on the new NCBIOIMPACT training consortium proposed by NCBIO. NCBIO is coordinating industry support and input for the Consortium.
University Research and Technology Transfer. Basic research is a wellspring of bioscience technology and business growth. NCBIO works to expand state funding for life science research grants and to protect and enhance university access to federal research dollars.
Tax and Regulatory Issues. Bioscience companies grow best in a nurturing business climate. NCBIO supports favorable tax treatment for biomanufacturing research and manufacturing expansions, government support for bioscience-related infrastructure. The Organization also aggressively opposes initiatives that depress the price of drugs and other health care products and seeks to assure that any new regulation of bioscience technologies is both necessary and rationale

“North Carolina now ranks as one of the top biotechnology regions in the United States and the world. NCBIO has become a strong, knowledgeable voice for the bioscience industry and for our superior business climate that ensures continued growth for the industry.” —Governor Mike Easley